Skip to main content
. 2021 Feb 3;7:6. doi: 10.1038/s41537-020-00133-0

Table 1.

Sample characteristics.

HC (n = 19) SZ (n = 45) Test statistics
(t/χ2/U) p Value
Age (years) 32.53 (9.45) 34.00 (10.47) t = −0.53 0.60
Sex (male/female) 9/10 31/14 χ2 = 2.64 0.10
Formal education (years)a 14.39 (2.23) 12.26 (3.88) U = 227 0.003
Number of hospitalizations 5.42 (5.44)
Outpatients/inpatients 24/21
Smoking (yes/no) 8/11 30/15 χ2 = 3.34 0.068
Number of psychotic episodes 5.31 (5.14)
Illness onset (age, years) 23.91 (6.88)
Illness duration (months) 121.07 (101.28)
Chlorpromazine equivalents (mg/day) 514.67 (444.82)
Clozapine (yes/no) 9/36
Class of antipsychotic (typical/atypical) 1/43
Antidepressant medication (yes/no) 5/40
Lorazepam (yes/no) 3/42
Body mass index 23.40 (4.32) 26.40 (4.66) U = 250 0.009
Psychopathology
PANSS negative factorb 15.49 (6.82)
PANSS positive factorc 5.96 (2.70)
PANSS disorganized factord 5.87 (2.48)
PANSS depressive factore 5.33 (2.45)
Cognition
Letter–Number Span Test 20.16 (2.06) 18.84 (1.93) t = 2.44 0.018
Symbol Coding Test 81.94 (18.75) 59.43 (13.28) t = 4.62 <0.001
Cognitive scoref 0 (0.68) −0.88 (0.70) t = 4.53 <0.001
Functioning
PSP (total) 97.05 (4.70) 51.78 (14.42) U = 2 <0.001

Data are presented as means (standard deviations). P values < 0.05 are indicated in bold.

BMI body mass index, HC healthy controls, PANSS Positive and Negative Syndrome Scale, PSP Personal and Social Performance Scale, SZ schizophrenia.

aCompulsory education in Switzerland is 9 years.

bNegative factor: N1, N2, N3, N4, N6, G7.

cPositive factor: P1, P3, P5, G9.

dDisorganized factor; P2, N5, G11.

eDepressive factor: P4, P7, G8, G14.

fCognition data have been z-transformed based on the data of the healthy control group for each test separately. The cognitive score was computed as the mean of the z-transformed test scores on subject level.